Skip to content

Ultrasound-Guided Anterior Quadratus Lumborum Combined with Parasacral Sciatic Plane Block versus Fascia Iliaca Compartment Block in Multimodal Analgesia for Total Hip Arthroplasty: A Prospective, Randomized, Double-Blind, Controlled Clinical Trial

Ultrasound-Guided Anterior Quadratus Lumborum Combined with Parasacral Sciatic Plane Block versus Fascia Iliaca Compartment Block in Multimodal Analgesia for Total Hip Arthroplasty: A Prospective, Randomized, Double-Blind, Controlled Clinical Trial - Anterior Quadratus Lumborum Block Combined with ParasanalSciatic Plane Block for Postoperative Analgesia after TotaHip Arthroplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118607
Enrollment
Unknown
Registered
2026-02-09
Start date
2026-02-26
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Hip Arthroplasty

Interventions

Group FICB:Ultrasound-Guided Fascia Iliaca Compartment Block
Group QLB-PIP:Ultrasound-guided anterior quadratus lumborum block combined with parasacral sciatic nerve plane block

Sponsors

The First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1: Age range 19–80 years 2: undergoing elective hip arthroplasty 3: ASA (American Society of Anesthesiologists) Classification I–III

Exclusion criteria

Exclusion criteria: 1: Underwent revision total hip arthroplasty 2: Allergic to study medications or contraindications for peripheral nerve block (local or systemic infection; pre-existing neurological deficits or neuropathy). 3: Any mental or psychiatric disorders that impede evaluation. 4: Allergy to any component of the analgesic regimen or local anesthetics. 5: Chronic opioid use (preoperative period =4 weeks, with a daily morphine equivalent dose =30 mg). 6: Suffering from severe cardiac, hepatic, or renal diseases. 7: Individuals with alcohol dependence.

Design outcomes

Primary

MeasureTime frame
24-hour morphine consumption;Block-related complications;

Secondary

MeasureTime frame
48-hour morphine consumption;12-hour morphine consumption;PACU pain score ;12h pain score ;24h pain score ;48h pain score ;24-hour movement-evoked pain;48-hour movement-evoked pain;24-hour quadriceps strength;Time to first active straight leg raise;Time to first ambulation;

Countries

China

Contacts

Public ContactQuanguang Wang

The First Affiliated Hospital of Wenzhou Medical University

quanguangwang@wzhospital.cn+86 137 6393 5500

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026